CLGN and CPT Related Headlines
Go Back- CollPlant receives nasdaq notice over $1 minimum bid requirement
- CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
- CollPlant Biotechnologies Launches Redesigned Corporate Website
- CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
- CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
- CollPlant announces $2.0 million registered direct offering
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
- COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
- CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
CLGN and CPT Related Press Releases
Go Back- CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
- CollPlant Biotechnologies Launches Redesigned Corporate Website
- CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
- CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
- COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
- CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
